CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma

Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study

(2016) Alaa A. Elzarkaa et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer

(2016) Takeshi Motohara et al.   OBSTETRICS AND GYNECOLOGY

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

(2016) Amanda Sosulski et al.   PLoS One

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer

(2015) Francisca Tjhay et al.   CANCER SCIENCE

Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma

(2015) Claire Bonneau et al.   GYNECOLOGIC ONCOLOGY

CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis

(2013) Jing Zhang et al.   HUMAN PATHOLOGY

Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade

(2012) Willi Oberaigner et al.   ACTA ONCOLOGICA

ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome

(2012) Yu-Chi Wang et al.   AMERICAN JOURNAL OF PATHOLOGY

CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival

(2012) Erhong Meng et al.   CLINICAL & EXPERIMENTAL METASTASIS

Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer

(2010) Michael et al.   Frontiers in Bioscience-Landmark